UK markets close in 28 minutes

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1400-0.0100 (-0.32%)
As of 10:58AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,456
391.695
1,503
208,383
12,617
Operating expenses
Research development
37,152
28,588
24,618
46,940
63,417
Selling general and administrative
34,032
31,086
32,432
37,233
30,631
Total operating expenses
71,184
59,674
57,050
84,173
94,048
Operating income or loss
-69,727
-59,282
-55,548
124,210
-81,431
Total other income/expenses net
714.912
2,000
1,379
-45.69
395.401
Income before tax
-69,014
-52,339
-54,169
124,163
-81,036
Income tax expense
-349.714
0
0
1,329
0
Income from continuing operations
-68,664
-52,339
-54,169
122,835
-81,036
Net income
-68,664
-52,339
-54,169
122,835
-81,036
Net income available to common shareholders
-67,814
-52,339
-54,169
119,837
-81,036
Basic EPS
-0.68
-0.74
-0.77
1.78
-1.39
Diluted EPS
-0.68
-0.74
-0.77
1.76
-1.39
Basic average shares
70,527
70,581
70,425
67,479
58,451
Diluted average shares
70,527
70,581
70,425
68,068
58,451